Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer.
Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer. J Clin Oncol. 1994 Apr; 12(4):683-8.